Indefinite Delivery Contract SPE2DX22D0029

Award Date 12/17/22
Last Date to Order 12/31/31
Federal Agency
Medical Supply Chain
Ultimate Awardee
Not listed
Federal Contract Vehicle
Pricing Type
Firm Fixed Price
Legislative Mandate
Not listed
National Interest Action
None
Award Type
Single
Primary Consortia Member
Not listed
  • SPE2DX22D0029
    Indefinite Delivery Contract
  • >10k
    Federal Contract Awards

The National Prime Vendor Generation IV contract will replenish pharmaceutical and related products to multiple ordering facilities supporting the Defense Health Agency's TRICARE Pharmacy Program, including sites associated with the TRICARE Mail Order Pharmacy and TRICARE Specialty Pharmacy Network. The contract will also provide readiness support and backup to CONUS Pharmaceutical Prime Vendor contracts. The Defense Logistics Agency Medical Directorate issued a Special Notice on June 24, 2020 seeking industry feedback on the draft Statement of Work by July 24, 2020 for the single award, firm-fixed price IDV with a one base and one option period not to exceed five years total. Pricing will be based on Federal Supply Schedule, DAPA, or regional DAPA prices plus the contractor's distribution fee and Cost Recovery Rate. The Notice aims to procure pharmaceutical distribution and related services for the TRICARE Pharmacy Program from a National Prime Vendor.

The associated task orders provided indicate Amerisourcebergen Drug Corp was awarded delivery orders against the Defense Logistics Agency Troop Support Medical contract IDV to supply pharmaceutical products and services for various dollar amounts to the PV Pharm Branch vendor location in Conshohocken, Pennsylvania. Performance periods are typically one day to support the agency's medical logistics responsibilities. The original solicitation suggests the National Prime Vendor Generation IV contract will service a maximum of 12 pharmacy ordering facilities nationwide.

Generated 1/4/24, 11:16 PM